Gastrointestinal side effects may be problematic for some fibromyalgia patients
This GLP-1 receptor agonist, used for type 2 diabetes management in the UK, is often paused before procedures due to delayed gastric emptying concerns
In individuals with non-alcoholic fatty liver disease, low doses of Semaglutide (0.10.4 mg) administered over 72 weeks is associated with enhanced physical function and increased energy levels, as reported through standardized self-assessments What the evidence suggests: Low-dose Semaglutide may improve physical function, emotional wellness, and overall quality of life
Judicial Panel on Multidistrict Litigation has created a separate MDL for cases alleging that GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Trulicity cause permanent vision loss from a condition known as NAION, assigning the new docket to Judge Karen Marston in the Eastern District of Pennsylvania
Ranbaxys first-filer economics on Lipitor were substantially structured around a negotiated authorized generic arrangement with Pfizer Pfizer launched its own authorized generic, partially offsetting Ranbaxys exclusivity value while preserving Pfizers ability to participate in the generic market during the transition
The rising prevalence was observed across demographic populations, with a substantial increase in developing countries compared to developed ones [5]